(Q77628508)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11840264%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

title

Radioimmunotherapy for model B cell malignancies using 90Y-labeled anti-CD19 and anti-CD20 monoclonal antibodies (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11840264%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

author name string

Ma D

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11840264%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

McDevitt MR

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11840264%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

Barendswaard E

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11840264%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

Lai L

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11840264%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

Curcio MJ

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11840264%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

Pellegrini V

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11840264%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

Brechbiel MW

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11840264%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

Scheinberg DA

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11840264%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

publication date

1 January 2002

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11840264%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11840264%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

volume

16

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11840264%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

page(s)

60-66

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11840264%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11840264%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/sj.leu.2402320

7 December 2019

exact match

0 references

cites work

Emerging immunotherapies for non-Hodgkin lymphomas: the tortoise approaches the finish line

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402320

7 January 2021

A new era for radiolabeled antibodies in cancer?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402320

7 January 2021

Maximum-tolerated dose, toxicity, and efficacy of (131)I-Lym-1 antibody for fractionated radioimmunotherapy of non-Hodgkin's lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402320

7 January 2021

Radiolabeled-antibody therapy of B-cell lymphoma with autologous bone marrow support

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402320

7 January 2021

Radioimmunotherapy of B-cell lymphoma with [131I]anti-B1 (anti-CD20) antibody

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402320

7 January 2021

Phase I/II trial of multiple dose 131Iodine-MAb LL2 (CD22) in patients with recurrent non-Hodgkin's lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402320

7 January 2021

CD19 antigen in leukemia and lymphoma diagnosis and immunotherapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402320

7 January 2021

A rapid, single vessel method for preparation of clinical grade ligand conjugated monoclonal antibodies

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402320

7 January 2021

Spectrophotometric method for the determination of a bifunctional DTPA ligand in DTPA-monoclonal antibody conjugates

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402320

7 January 2021

Follow-up of relapsed B-cell lymphoma patients treated with iodine-131-labeled anti-CD20 antibody and autologous stem-cell rescue

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402320

7 January 2021

99mTc-CD19 monoclonal antibody is not useful for imaging of B cell non-Hodgkin's lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402320

7 January 2021

Degradation of radioiodinated B cell monoclonal antibodies: inhibition via a FCgamma-receptor-II-mediated mechanism and by drugs

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402320

7 January 2021

Advantage of residualizing radiolabels for an internalizing antibody against the B-cell lymphoma antigen, CD22.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402320

7 January 2021

Therapy of B-cell lymphomas with monoclonal antibodies and radioimmunoconjugates: the Seattle experience.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402320

7 January 2021

Immunotoxins against CD19 and CD22 are effective in killing precursor-B acute lymphoblastic leukemia cells in vitro

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402320

7 January 2021